Procyon Corp. (PCYN) news stock charts
Procyon Corp. (PCYN/PCYN.OB) Investment Summary:
Procyon Corporation, through its subsidiary, Amerx Health Care Corp., engages in the development and marketing of medical products used in the treatment of pressure ulcers, dermatitis, inflammation, and other skin problems in the United States. Its products include AmeriGel Hydrogel Wound Dressing and Amerigel Hydrogel Saturated Gauze Dressing, which are used as a wound dressing to manage stages I-IV pressure ulcers, stasis ulcers, diabetic skin ulcers, post surgical incisions, cuts, abrasions, first and second degree burns, and skin irritations; and AmeriGel Preventive Care Lotion, a therapeutic skin conditioner containing emollients that restore moisture to fragile skin, protect the skin a...11 Employees
Founded in 1987
PROCYON CORP (PCYN:OTC Bulletin Board Market)
LAST $0.16 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of 8:10 PM 03/16/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of PROCYON CORP (PCYN)
|
OPEN
$0.16
|
PREVIOUS CLOSE
$0.16
|
|
|
DAY HIGH
$0.16
|
DAY LOW
$0.16
|
|
|
52 WEEK HIGH
03/15/10 - $0.25
|
52 WEEK LOW
05/14/09 - $0.06
|
|
|
MARKET CAP
1.3M
|
AVERAGE VOLUME 10 D
3.7K
|
|
|
EPS TTM
--
|
SHARES OUTSTANDING
8.1M
|
|
|
PCYN Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for PROCYON CORP (PCYN)
Procyon Corp., Annual General Meeting, Dec 08, 2009
11/9/2009
Procyon Corp., Annual General Meeting, Dec 08, 2009, at 16:00 US Eastern Time. Location: 1300 S. Highland Ave, Clearwater, FL 33756, United States. Agenda: To elect eight directors to hold office for the term set forth in the accompanying Proxy Statement and until their successors shall have been duly elected and qualified; to ratify the appointment of Ferlita, Walsh, & Gonzalez P.A. as independent registered public accountants for the 2010 fiscal year; to approve the company's 2009 stock option plan; and to consider and transact such other business as may properly come before the meeting or any adjournment thereof.
Procyon Corp. Announces Resignation of Alan C. Crane to the Board of Directors and Member of the Ethics Committee of the Board
08/3/2009
Procyon Corp. announced that on July 14, 2009, Alan C. Crane, a director of the company since 1995, tendered his resignation for personal reasons to the board of directors, which regretfully accepted his resignation. Mr. Crane's resignation was not due to any disagreement with the company or its board of directors on any matter relating to the company's operations, policies or practices. At the time of his resignation from the board, Mr. Crane was also a member of the Ethics Committee of the board of directors, and therefore, effectively resigned from that committee as well.
Procyon Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2009
05/18/2009
Procyon Corp. reported earnings results for the third quarter ended March 31, 2009. For the period, the company showing a net income of $28,856. In contrast, the company posted a net income of $12,126 for the same quarter in the previous year.
Procyon Corp. financial resources
PCYN Competitors
| Company | Last | Change | |
| No competitor information is available for PCYN. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | PCYN | Industry Range |
| Price/Earnings | 15.0x |
|
| Price/Sales | 0.5x |
|
| Price/Book | 0.7x |
|
| Price/Cash Flow | 14.4x |
|
| TEV/Sales | NM | Not Meaningful |
|
PCYN |
||
|
PCYN transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Procyon Corp.
Compensation changes drag down bottom line at Procyon
2010-02-18 06:15:27
Quote: Procyon Corp. reported a net loss of $30,000 for the three months ended Dec. 31, compared with net income of $5,337 in the same period a year ago.The company did not report any earnings per share for either period.Revenue was $548,644 in the just-ended quarter, an increase of about 1 percent from $542,914 a year earlier. Higher sales of skin and wound care products accounted for the increase in revenue, the company said in a filing with the Securities and Exchange Commission. But expenses also i...Read article
Paul Guilbaud quits Procyon board
2009-12-15 01:26:10
Quote: Paul Guilbaud, a veteran of the pharmaceutical and medical device industry, withdrew his acceptance to serve on the board of directors of Procyon Corp., shortly after shareholders elected him to the post.Guilbaud had been unanimously nominated by the Procyon board to stand for election, and he agreed to do so, Procyon said in a Nov. 9 proxy filing. But subsequent to the annual shareholders meeting on Dec. 8, he withdrew his acceptance, citing potential conflicts of interest in connection with a ...Read article
PROCYON CORP Files SEC form 8-K, Other Events
2009-12-15 01:26:10
Quote: PROCYON CORPRequest a Trial to NEW EDGAR Online Pro
Form
8-K for
PROCYON CORP
14-Dec-2009Other EventsPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, or for any actions taken in re...Read article
Fee increases cut Procyon profit
2009-11-30 03:56:48
Quote: Procyon Corp. reported $4,765 in net income, or 0 cents a share, for the fiscal year ended June 30, compared to $778,071, or 10 cents a share, in the prior fiscal year.Revenue for fiscal 2009 was $2.4 million, compared with $2.3 million in the prior year.In a Securities and Exchange Commission filing, the Clearwater-based medical supply firm said increased marketing and regulatory costs negatively impacted its income. The company specifically cited legal, consulting and accounting fees.Procyon (...Read article
PROCYON CORP Files SEC form 10-K, Annual Report
2009-11-30 03:56:48
Quote: The results of
operations for fiscal 2009 and 2008 are being reported to reflect continuing
operations for Procyon and Amerx, with discontinued operation of Sirius.
Net sales during fiscal 2009 were approximately $2,366,000 as compared to
approximately $2,254,000 in fiscal 2008, an increase of approximately $112,000,
or 5%. Amerx sales were impacted by the general economic conditions effect on
the health care market. Increases were seen in quarterly sales for three of the
four quarters when comp...Read article
Skin, wound care products drive gains at Procyon
2009-11-30 03:56:47
Quote: Procyon Corp. reported net income of $73,622, or 1 cent a share, for the three months ended Sept. 30, compared with net income of $9,051, or 0 cents a share, in the same period in 2008.Revenue for the just-ended quarter, the first quarter of the company’s fiscal year, was $671,816, a 12.7 percent increase from revenue of $596,237 for the year-ago period, the company said in a filing with the Securities and Exchange Commission.Revenue was up primarily because of an increase in skin and woun...Read article
Would you like to leave a comment about Procyon Corp. PCYN/PCYN.OB
Find out what social network information about Procyon Corp. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Procyon Corp.'s Stock there is more great penny stock and market information at Realpennies